SCYNEXIS, Inc. Current Assets
SCYNEXIS, Inc. (SCYX) had Current Assets of $56.24 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-10
- 2026-06-30: Assets, Current $56.24M.
- 2026-03-31: Assets, Current $62.69M.
- 2025-12-31: Assets, Current $40.37M.
- 2025-09-30: Assets, Current $48.69M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $56.24M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $62.69M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $40.37M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $48.69M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $56.50M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $52.22M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $72.18M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $80.46M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $94.58M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $101.67M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $102.12M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $128.64M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $145.53M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $59.77M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $79.06M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $103.56M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $125.68M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $101.91M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $109.38M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $103.93M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $115.63M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $95.38M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $98.21M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $32.31M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $40.57M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $36.79M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $52.40M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $28.96M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $36.14M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $40.07M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $51.46M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $50.23M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $56.51M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $64.34M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $44.96M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $48.72M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $50.85M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $55.59M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $59.33M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $54.19M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $52.74M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $39.92M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $48.44M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $55.92M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $64.64M 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $34.57M 8-K · filed 2015-10-30 | $29.83M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $39.65M 10-K · filed 2016-03-07 | $34.74M 10-K · filed 2015-03-30 |
| 2014-09-30 | $36.80M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $40.80M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $2.29M 10-Q/A · filed 2014-07-11 | |
| 2013-12-31 | $8.44M 8-K · filed 2015-10-30 | $2.95M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |